3. How to take Gaviscon
4. Possible side effects
5. Storage of Gaviscon
6. Contents of the pack and additional information
It belongs to the group of medications known as other agents against peptic ulcers and gastroesophageal reflux.
It acts in two different ways:
1. Sodium alginate together with sodium hydrogenocarbonate (bicarbonate) and calcium carbonate form a protective barrier in the stomach to prevent gastric reflux and calm heartburn in the stomach.
2. Sodium hydrogenocarbonate (bicarbonate) and calcium carbonate neutralize excess acid in the stomach.
Gaviscon is indicated for the symptomatic treatment of hyperacidity of the stomach andtheheartburn caused by the acidic reflux of the stomach,inadultsandchildrenover12years.
You should consult a doctor if it worsens or does not improve after 7 days.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take this medication if: you have mild or moderate kidney problems, have been diagnosed with sarcoidosis (inflammation that can affect multiple organs in the body), suffer from constipation or hemorrhoids, or suffer from symptoms of stomach or intestinal diseases, appendicitis, or edema.
If you are taking or have to take other medications, separate your intake by 1 to 2 hours (see"Other medications andGaviscon").
Avoid prolonged use as it may cause kidney stones, as well as high levels of calcium in the blood or urine, kidney insufficiency, or worsening it if you already have it.
This medication should not be taken with milk or dairy products.
If symptoms persist after 7 days of treatment, consultwith your doctor.
Children and adolescents
Gaviscon is not recommended for children under 12 years old.
Interference with analytical tests
If you are to undergo any analytical test (including blood, urine, skin tests that use allergens, etc.) inform your doctor that you are taking this medication, as it may alter the results.
Other medications and Gaviscon
Inform your doctor or pharmacist if you are taking, have taken recently, or may have to take any other medication.
Before taking this medication, inform your doctor if you are takingantibiotics (tetracyclines, quinolones), heart medications such as cardiac glycosides (digoxinordigitoxin) or other medicationslikefluorides, phosphates,sodium iron salts, ketoconazole, neuroleptics, thyroid hormones, penicillamine, glucocorticoids, chloroquine, diphosphonates, or beta-blockers (such as atenolol, metoprolol, propranolol) or estramustine,as it may affect the efficacy of these medications.
As Gavisconmay interfere with some medications, after taking it, wait 2 hours before taking another oral medication. If you have taken another medication, wait 1 to 2 hours before taking Gaviscon to get the maximum benefit from the treatment with that other medication.
Taking Gaviscon with food and drinks
Like all calcium-containing antacids, this medication should not be taken with large amounts of milk or dairy products as it may cause an increase in blood calcium levels and milk-alkali syndrome (Burnett syndrome).
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This medication can be used during pregnancy and breastfeeding if taken according to these recommendations and not taken for a long time.
As this medication provides a significant amount of calcium in addition to what the pregnant woman or breastfeeding woman takes each day, pregnant women or breastfeeding women cannot exceed the amounts indicated in the section "3. How to take Gaviscon"and cannot take, at the same time, large amounts of dairy products and milk (1 liter of milk contains 1.2 grams of elemental calcium).
Driving and operating machines
This medication does not affect the ability to drive or operate machines.
Gaviscon contains sodium andaspartame.
This medication contains 254.84 mg of sodium (mainly table salt/for cooking) in each 4 tablets. This is equivalent to 12.74% of the maximum daily sodium intake recommended for an adult.
Consult your doctor or pharmacist if you need 7 or more tablets daily for a prolonged period, especially if you have been recommended a low-sodium diet.
This medication contains 35.2 mg of aspartame in each 4 tablets.
Aspartame contains a source of phenylalanine that may be harmful in the case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Follow exactly the administration instructions of the medication contained in this leaflet or those indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose in adults, including older people and adolescents over 12 years, is 2 to 4 tablets as needed, 1 hour after meals and before going to bed. A maximum of 16 tablets can be taken per day.
Renal Insufficiency:Caution is required in patients with low-sodium diets (see section 2).
Howto Take
This medication is taken orally.
Remove the tablets from the packaging and chew them.
If symptoms persist after 7 days of continuous treatment, consult your doctor to rule out more serious diseases.
If you take more Gaviscon than you should
The symptoms of overdose include nausea and vomiting, constipation, fatigue, increased urine production, thirst, dehydration, and abnormal muscle weakness.
Drink plenty of water and consult your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or visit a medical center or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Gaviscon
Do not take a double dose to compensate for the missed doses.
When needed, take it again as indicated in the section "3. How to Take Gaviscon". If you have any other questions about the use of this medication, ask your doctor or pharmacist.
During the period of use of the association of sodium alginate, hydrogenocarbonate (bicarbonate) of sodium and calcium carbonate, the following adverse effects have been observed with the following frequencies:
Unknown frequency (frequency cannot be estimated from available data):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use (www.notificaram.es). By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medications thatitdoesnotneedatthePharmacyCollectionPointSIGRE.Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
Gaviscon Composition
The active principles are 250 mg of sodium alginate, 133.5 mg of sodium hydrogen carbonate (bicarbonate) and 80 mg of calcium carbonate.
The other components (excipients) are: macrogol, mannitol (E-421), aspartame (E-951), magnesium stearate, xylitol DC (which contains sodium caramel), strawberry flavor (which contains cornstarch, vegetable oil, propylene glycol (E-1520)), iron oxide red.
Product appearance and packaging contents
Gaviscon are pale pink, flat, beveled-edged chewable tablets with a strawberry odor and taste.
They are presented in PVC/PE/PVdC transparent, unprinted strips with an aluminum foil layer in a cardboard container with the leaflet.
Each package may contain 4, 24, 32, 48 and 64 tablets.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Reckitt Benckiser Healthcare, S.A.
C/ Mataró, 28
08403 Granollers-Barcelona (Spain)
Spain
RB NL Brands B.V.
Schiphol Blvd 207, 1118 BH Schiphol, Netherlands
Revision date of this leaflet:August 2020.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.